| Literature DB >> 28150362 |
Claus F Vogelmeier1, Gerard J Criner2, Fernando J Martinez3, Antonio Anzueto4,5, Peter J Barnes6, Jean Bourbeau7, Bartolome R Celli8, Rongchang Chen9, Marc Decramer10, Leonardo M Fabbri11, Peter Frith12, David M G Halpin13, M Victorina López Varela14, Masaharu Nishimura15, Nicolas Roche16, Roberto Rodriguez-Roisin17, Don D Sin18, Dave Singh19, Robert Stockley20, Jørgen Vestbo19, Jadwiga A Wedzicha6, Alvar Agusti21.
Abstract
This Executive Summary of the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 Report focuses primarily on the revised and novel parts of the document. The most significant changes include: (i) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; (ii) for each of the groups A to D, escalation strategies for pharmacological treatments are proposed; (iii) the concept of de-escalation of therapy is introduced in the treatment assessment scheme; (iv)non-pharmacological therapies are comprehensively presented and (v) the importance of co-morbid conditions in managing COPD is reviewed.Entities:
Keywords: COPD diagnosis; COPD management; COPD prevention; chronic obstructive pulmonary disease
Mesh:
Year: 2017 PMID: 28150362 DOI: 10.1111/resp.13012
Source DB: PubMed Journal: Respirology ISSN: 1323-7799 Impact factor: 6.424